Skip to main content

Advertisement

Log in

Achromobacter xylosoxidans Pneumonia in a Young Child with Chronic Granulomatous Disease—a Case-Based Review

  • Letter to Editor
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Dworzack DL, Murray CM, Hodges GR, Barnes WG. Community-acquired bacteremic Achromobacter xylosoxidans type IIIa pneumonia in a patient with idiopathic IgM deficiency. Am J Clin Pathol. 1978 Oct;70(4):712–7.

    Article  CAS  Google Scholar 

  2. Weitkamp JH, Tang YW, Haas DW, Midha NK, Crowe JE. Recurrent Achromobacter xylosoxidans bacteremia associated with persistent lymph node infection in a patient with hyper-immunoglobulin M syndrome. Clin Infect Dis. 2000 Nov;31(5):1183–7.

    Article  CAS  Google Scholar 

  3. Jaggi P, Freeman AF, Katz BZ. Chronic granulomatous disease presenting with eosinophilic inflammation. Pediatr Infect Dis J. 2005 Nov;24(11):1020–1.

    Article  Google Scholar 

  4. Sheehan WJ, Delmonte OM, Miller DT, Roberts AE, Bonilla FA, Morra M, et al. Novel presentation of Omenn syndrome in association with aniridia. J Allergy Clin Immunol. 2009 Apr;123(4):966–9.

    Article  Google Scholar 

  5. D’Aversa P, Leo L, Civino A, Monteduro MG, Russo L, Cosi M, et al. A case of chronic otitis caused by Achromobacter xylosoxidans in children with severe combined immunodeficiency (SCID). Microbiologia Medica. 2009 Dec 31;24(4):263–4.

    Google Scholar 

  6. Zegarra-Linares R, Ang JY, Khan F, Asmar BI, McGrath EJ. A teenager patient with recurrent pulmonary abscesses. J Pediatr Infect Dis Soc. 2014 Jun;3(2):e20–3.

    Article  Google Scholar 

  7. Burns SO, Plagnol V, Gutierrez BM, Al Zahrani D, Curtis J, Gaspar M, et al. Immunodeficiency and disseminated mycobacterial infection associated with homozygous nonsense mutation of IKKβ. J Allergy Clin Immunol. 2014 Jul;134(1):215–8.

    Article  CAS  Google Scholar 

  8. Engelhardt KR, Gertz ME, Keles S, Schäffer AA, Sigmund EC, Glocker C, et al. The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol. 2015 Aug;136(2):402–12.

    Article  CAS  Google Scholar 

  9. Duraisingham SS, Manson A, Grigoriadou S, Buckland M, Tong CY, Longhurst HJ. Immune deficiency: changing spectrum of pathogens. Clin Exp Immunol. 2015 Aug;181(2):267–74.

    Article  CAS  Google Scholar 

  10. Mwangi JK, Powers B, Stoeckel D. D32 interesting cases in allergy and immunology: bronchiectasis due to selective immunoglobulin M deficiency. Am J Respir Crit Care Med. 2015;191:1.

    Article  Google Scholar 

  11. Singh A, Hussain A, Jain R, Aishwarya K, Tak V, Thakur P. Achromobacter xylosoxidans septic arthritis in a child with primary immunodeficiency. J Global Infect Dis. 2017 Mar;9(1):36–7.

    Article  Google Scholar 

  12. Özışık L, Cebrayilov C, Başaran NÇ, Güven GS. Hepatic granuloma mimicking tuberculosis: Achromobacter xylosoxidans in a patient with familial Mediterranean fever. Acta Med Austriaca. 2017 Mar 31;48(1):37–40.

    Google Scholar 

  13. McCormack RM, Szymanski EP, Hsu AP, Perez E, Olivier KN, Fisher E, et al. MPEG1/perforin-2 mutations in human pulmonary nontuberculous mycobacterial infections. JCI Insight. 2017 Apr;20:2(8).

    Google Scholar 

  14. Janarthanan M, Gollapalli S, Sankaranarayanan S. Achromobacter xylosoxidans sepsis unveiling X-linked agammaglobulinemia masquerading as systemic-onset juvenile idiopathic arthritis. Indian Pediatr. 2019 May 15;56(5):423–5.

    Article  Google Scholar 

  15. Więsik-Szewczyk E, Jahnz-Różyk K. From infections to autoimmunity: diagnostic challenges in common variable immunodeficiency. World J Clin Cases. 2020 Sep 26;8(18):3942–55.

    Article  Google Scholar 

  16. Więsik-Szewczyk E, Ziętkiewicz M, Matyja-Bednarczyk A, Napiórkowska-Baran K, Suchanek H, Jahnz-Różyk K. The first polish cohort of adult patients with common variable immunodeficiency from 4 specialized centers: do we provide standards of care? Pol Arch Intern Med. 2018 Sep 28;128(9):563–6.

    PubMed  Google Scholar 

  17. Lu HY, Sharma M, Biggs CM, Huang YH, Shopsowitz KE, Frosk P, et al. The importance of functional validation after next-generation sequencing: evaluation of a novel CARD11 variant. Pediatr Allergy Immunol. 2018 Sep;29(6):663–8.

    Article  Google Scholar 

  18. Xie M, Lee J, Crespo M, Fajt ML, Shigemura N, Pilewski JM, et al. Successful lung transplantation in a patient with chronic granulomatous disease. J Clin Immunol. 2019 May;39(4):347–9.

    Article  Google Scholar 

  19. Rawat A, Jindal AK, Suri D, Vignesh P, Gupta A, Saikia B, et al. Clinical and genetic profile of X-linked agammaglobulinemia: a multicenter experience from India. Front Immunol. 2020;11:612323.

    Article  CAS  Google Scholar 

  20. Leusen JH, de Boer M, Bolscher BG, Hilarius PM, Weening RS, Ochs HD, et al. A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox. J Clin Invest. 1994 May;93(5):2120–6.

    Article  CAS  Google Scholar 

  21. The Human Gene Mutation Database, accession number CM025325; http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CYBB. Date accessed 24th March 2021.

  22. Wu J, Wang WF, Zhang YD, Chen TX. Clinical features and genetic analysis of 48 patients with chronic granulomatous disease in a single center study from Shanghai, China (2005-2015): new studies and a literature review. J Immunol Res. 2017;2017:8745254.

    PubMed  PubMed Central  Google Scholar 

  23. Spear JB, Fuhrer J, Kirby BD. Achromobacter xylosoxidans (Alcaligenes xylosoxidans subsp. xylosoxidans) bacteremia associated with a well-water source: case report and review of the literature. J Clin Microbiol. 1988 Mar;26(3):598–9.

    Article  CAS  Google Scholar 

  24. Kowalczyk A, Chyc M, Ryszka P, Latowski D. Achromobacter xylosoxidans as a new microorganism strain colonizing high-density polyethylene as a key step to its biodegradation. Environ Sci Pollut Res Int. 2016 Jun;23(11):11349–56.

    Article  CAS  Google Scholar 

  25. Igra-Siegman Y, Chmel H, Cobbs C. Clinical and laboratory characteristics of Achromobacter xylosoxidans infection. J Clin Microbiol. 1980 Feb;11(2):141–5.

    Article  CAS  Google Scholar 

  26. Gómez-Cerezo J, Suárez I, Ríos JJ, Peña P, García de Miguel MJ, de José M, et al. Achromobacter xylosoxidans bacteremia: a 10-year analysis of 54 cases. Eur J Clin Microbiol Infect Dis. 2003 Jun;22(6):360–3.

    Article  Google Scholar 

  27. Tatro ET, Purnajo I, Richman DD, Smith DM, Gianella S. Antibody response to Achromobacter xylosoxidans during HIV infection is associated with lower CD4 levels and increased lymphocyte activation. Clin Vaccine Immunol. 2014 Jan;21(1):46–50.

    Article  CAS  Google Scholar 

  28. De Baets F, Schelstraete P, Van Daele S, Haerynck F, Vaneechoutte M. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance. J Cyst Fibros. 2007 Jan;6(1):75–8.

    Article  Google Scholar 

  29. Legrand C, Anaissie E. Bacteremia due to Achromobacter xylosoxidans in patients with cancer. Clin Infect Dis. 1992 Feb 1;14(2):479–84.

    Article  CAS  Google Scholar 

Download references

Authors’ Contribution Statement

PKP: Inception of the idea, writing of initial draft of the manuscript, editing and revision of manuscript, patient evaluation and management, data collection, review of literature, and final approval.

AZB: Writing of initial draft of the manuscript, editing and revision of manuscript, patient evaluation and management, data collection, review of literature, and final approval.

PS: Editing and revision of the manuscript, patient evaluation and management, and final approval.

BS/AA: Performed microbiology investigations, editing of manuscript, and final approval.

PV: Patient management and follow-up, editing and revision of the manuscript, overall supervision of manuscript preparation, and final approval.

AR: Performed flow cytometry and genetic testing, editing and revision of the manuscript, overall supervision of manuscript preparation, and final approval.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pandiarajan Vignesh.

Ethics declarations

Ethical Approval and Informed Consent

As this manuscript pertains only to a case report and literature review specific ethics approval is not mandated. Informed consent was taken from the parents of the child before inclusion into the manuscript.

Competing Interest for all Authors

No financial or nonfinancial benefits have been received or will be received from any party related directly or indirectly to the subject of this article.

Achromobacter xylosoxidans pneumonia in a young child with chronic granulomatous disease—a case-based review.

Conflict of Interest

None.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Patra, P.K., Banday, A.Z., Sadanand, R. et al. Achromobacter xylosoxidans Pneumonia in a Young Child with Chronic Granulomatous Disease—a Case-Based Review. J Clin Immunol 41, 1686–1692 (2021). https://doi.org/10.1007/s10875-021-01079-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-021-01079-3

Navigation